Professional Services

Accelerate breakthroughs with our tailored enablement services
Improve efficiency, accuracy, and scalability of your workflows with professional services driven by skilled personnel, proven solutions, and steadfast dedication.
Request a Demo
Home breadcrumb-arrow Professional Services
OVERVIEW

Maximize the power of genomics data to drive global health equity

The emergence of precision medicine and the advances in AI and molecular techniques is transforming the way research in drug development is conducted. Genetic testing has become pivotal to accessing precision therapies however, there’s a gap in the accessibility and adoption of NGS-based testing across the globe.
Leverage our expertise in developing and deploying genomics applications and the data generated within the SOPHiA GENETICS network to enhance patient and market access to relevant genomic information, and match patients to the right clinical trials and treatments.
*SOPHiA DDMTM Clinical Trial Assay and SOPHiA DMMTM Follow-on Dx can be further validated to Companion Diagnostic (CDx) level

Streamline your daily work

Our suite of professional services enables you to focus on high-value work and make faster, more effective, and confident data-driven decisions.

Maximizing efficiency, caring for excellence

Implementing a genomics application is complex and time-consuming. The SOPHiA DDM™ MaxCare Program empowers labs achieving trusted high-quality results, while meeting stringent standards. Our experts provide on-site consultation, hands-on training, and performance assessments for seamless workflow implementation, enhancing your data’s statistical power.
With 550+ programs completed across 360+ institutions, we offer proven expertise in adopting diverse NGS-based applications, facilitating your lab self-validation and accreditation efforts.
Accelerated adoption
Expect ~120 days from onboarding to completion, with seamless implementation of genomics applications, tailored to your requirements.
Increased efficiency
Optimize your workflows with comprehensive training on genomics applications, adapted to your needs, throughout the full onboarding process.
Enhanced confidence
Obtain verification support to meet and exceed your standard and increase confidence in your results, while leveraging your samples and workflows.

Streamlining data integration for enhanced efficiency

Dealing with data from multiple, siloed sources is a manual, error prone, and non-scalable process. The SOPHiA DDM™ Platform automates data management and pipeline execution and increases productivity by eliminating the need to manually upload sequencer output files, enter Electronic Health Records (EHR), and input Laboratory Information Management Systems (LIMS) data.
Leverage our collaboration with external service providers to foster seamless, automated data flow between your instruments, EHR, LIMS and the SOPHiA DDM™ Platform.
Enhanced efficiency
Automate manual tasks to boost your productivity. Spend less time on redundant manual processes, and more time on high-value work.
Improved scalability
Streamline your workflows to rapidly and efficiently deliver comprehensive and integrated genomics analysis by automating data flows.
Increased accuracy
Reduce data entry errors by connecting SOPHiA DDM™ to various databases and systems to extract more insights from your data through downstream analysis.

Increase productivity with a standardized NGS workflow

Manual liquid handling presents challenges for lab technicians with heavy workloads, potentially leading to errors and variability, especially when working with small samples and complex library preparation protocols.
Maximize your efficiency by automating your library preparation. By combining SOPHiA GENETICS™ sample‑to‑report applications with automated liquid handling platforms, you can standardize your NGS workflow and minimize manual intervention.
Enhanced productivity
Minimize human intervention to increase productivity, while reducing errors and saving resources.
Standardized workflows
Obtain high-quality libraries with standardized protocols to ensure reliable analytical performance.
Expert support
Get the needed fit-for-purpose support from instrument pre-installation to long-term projects.

Empowering your internal validation efforts

One of the biggest blockers in validating a genomic application is the availability of tumor-normal clinical samples containing variants of interest. Not only is it critical to have a sufficient number of samples to ensure optimal coverage, but also of good quality to ensure robust results.
With an empower-forward network, SOPHiA GENETICS™ Sample Sourcing, we help you find high-quality samples to streamline your validation workflows in a simple manner and efficiently implement NGS-based workflows in your laboratory.
Accelerated adoption
Fasten your time-to-implementation and remove blockers during your validation process.
Tailored approach
Reach your verification and validation needs with the right sample strategy and our experts consultative approach.
Access to a global network
Connect with like-minded sites and benefit from mutual support during your validation journey.

“Through this collaboration, we aim to enable the widespread application of precision medicine in oncology across Africa, and thus contributing to the improvement of patient outcomes across the African continent.

“Our collaboration with SOPHiA GENETICS has the potential to uncover genomic mutations that correlate with clinical response to ADCT-402. We have observed significant single-agent clinical activity in our pivotal Phase II trial of ADCT-402 in a broad population of patients with relapsed or refractory diffuse large B-cell lymphoma. The insights from this collaboration will allow us to better identify and understand the characteristics of patients who respond best to treatment. We look forward for the results of this research enabled by SOPHiA’s unique platform”
Patrick van Berkel
Sr VP of Research and Development, ADC Therapeutics

SOPHiA GENETICS products are for Research Use Only and not for use in diagnostic procedures unless specified otherwise.

SOPHiA DDM™ Dx Hereditary Cancer Solution, SOPHiA DDM™ Dx RNAtarget Oncology Solution and SOPHiA DDM™ Dx Homologous Recombination Deficiency Solution are available as CE-IVD products for In Vitro Diagnostic Use in the European Economic Area (EEA), the United Kingdom and Switzerland. SOPHiA DDM™ Dx Myeloid Solution and SOPHiA DDM™ Dx Solid Tumor Solution are available as CE-IVD products for In Vitro Diagnostic Use in the EEA, the United Kingdom, Switzerland, and Israel. Information about products that may or may not be available in different countries and if applicable, may or may not have received approval or market clearance by a governmental regulatory body for different indications for use. Please contact us at support@sophiagenetics.com to obtain the appropriate product information for your country of residence.

All third-party trademarks listed by SOPHiA GENETICS remain the property of their respective owners. Unless specifically identified as such, SOPHiA GENETICS’ use of third-party trademarks does not indicate any relationship, sponsorship, or endorsement between SOPHiA GENETICS and the owners of these trademarks. Any references by SOPHiA GENETICS to third-party trademarks is to identify the corresponding third-party goods and/or services and shall be considered nominative fair use under the trademark law.

SOPHiA DDM™ Overview
Unlocking Insights, Transforming Healthcare
Learn About SOPHiA DDM™ 
SOPHiA DDM™ for Genomics

Oncology 

Rare and Inherited Disorders

Add-On Modules

SOPHiA DDM™ for Radiomics
Unlock entirely novel insights from your radiology images
Learn About SOPHiA DDM™ for Radiomics 
SOPHiA DDM™ for Multimodal
Explore new frontiers in biology and disease through novel insights
Learn About SOPHiA DDM™ for Multimodal
Professional Services
Accelerate breakthroughs with our tailored enablement services
Learn About our Professional Services